122 related articles for article (PubMed ID: 9473219)
1. Both stroma and stem cell factor maintain long-term growth of ELM erythroleukemia cells, but only stroma prevents erythroid differentiation in response to erythropoietin and interleukin-3.
O'Prey J; Leslie N; Itoh K; Ostertag W; Bartholomew C; Harrison PR
Blood; 1998 Mar; 91(5):1548-55. PubMed ID: 9473219
[TBL] [Abstract][Full Text] [Related]
2. An activating mutation in the kit receptor abolishes the stroma requirement for growth of ELM erythroleukemia cells, but does not prevent their differentiation in response to erythropoietin.
Leslie NR; O'Prey J; Bartholomew C; Harrison PR
Blood; 1998 Dec; 92(12):4798-807. PubMed ID: 9845547
[TBL] [Abstract][Full Text] [Related]
3. Stem cell factor and stromal cell co-culture prevent apoptosis in a subculture of the megakaryoblastic cell line, UT-7.
Liesveld JL; Harbol AW; Abboud CN
Leuk Res; 1996 Jul; 20(7):591-600. PubMed ID: 8795693
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and differentiation of erythroleukemia cell line (ELM-I-1) in response to erythropoietin and interleukin 3.
Shiozaki M; Itoh K; Mori KJ
Leuk Res; 1990; 14(3):287-91. PubMed ID: 2319808
[TBL] [Abstract][Full Text] [Related]
5. Stem cell factor influences the proliferation and erythroid differentiation of the MB-02 human erythroleukemia cell line by binding to a high-affinity c-kit receptor.
Broudy VC; Morgan DA; Lin N; Zsebo KM; Jacobsen FW; Papayannopoulou T
Blood; 1993 Jul; 82(2):436-44. PubMed ID: 7687159
[TBL] [Abstract][Full Text] [Related]
6. The role of soluble growth factors in inducing transient growth and clonal extinction of stroma cell dependent erythroblastic leukemia cells.
Itoh K; Friel J; Laker C; Zeller W; Just U; Bittner S; Nibbs RJ; Harrison PR; Nishikawa SI; Mori KJ; Ostertag W
Leukemia; 1997 Oct; 11(10):1753-61. PubMed ID: 9324297
[TBL] [Abstract][Full Text] [Related]
7. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro.
Panzenböck B; Bartunek P; Mapara MY; Zenke M
Blood; 1998 Nov; 92(10):3658-68. PubMed ID: 9808559
[TBL] [Abstract][Full Text] [Related]
8. Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53.
Nibbs RJ; Itoh K; Ostertag W; Harrison PR
Mol Cell Biol; 1993 Sep; 13(9):5582-92. PubMed ID: 8355701
[TBL] [Abstract][Full Text] [Related]
9. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
10. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
11. Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11.
Hassan HT; Biermann B; Zander AR
Eur Cytokine Netw; 1996; 7(2):129-36. PubMed ID: 8688490
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.
Okajima Y; Matsumura I; Nishiura T; Hashimoto K; Yoshida H; Ishikawa J; Wakao H; Yoshimura A; Kanakura Y; Tomiyama Y; Matsuzawa Y
J Biol Chem; 1998 Sep; 273(36):22877-83. PubMed ID: 9722506
[TBL] [Abstract][Full Text] [Related]
13. Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors.
Miyagawa S; Kobayashi M; Konishi N; Sato T; Ueda K
Br J Haematol; 2000 Jun; 109(3):555-62. PubMed ID: 10886204
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin rapidly reduces phosphorylation of a membrane protein in a murine erythroleukemia cell line.
Sawada T; Tsuda H; Mori KJ; Kawakita M; Takatsuki K
Int J Hematol; 1991 Apr; 54(2):109-15. PubMed ID: 1836139
[TBL] [Abstract][Full Text] [Related]
15. Stromal cell-dependent growth of leukemic cells from murine erythroblastic leukemia.
Itoh K; Sasaki R; Ono K; Tezuka H; Sakoda H; Sawada H; Hitomi K; Nakane H; Uchiyama T; Uchino H
Jpn J Cancer Res; 1988 Aug; 79(8):931-7. PubMed ID: 2460423
[TBL] [Abstract][Full Text] [Related]
16. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.
Verfaillie CM
Blood; 1993 Oct; 82(7):2045-53. PubMed ID: 7691246
[TBL] [Abstract][Full Text] [Related]
17. Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor.
Pierelli L; Scambia G; Menichella G; Fattorossi A; Ciarli M; Bonanno G; Battaglia A; d'Onofrio G; Benedetti Panici P; Iacone A; Mancuso S; Leone G
Br J Haematol; 1997 Jan; 96(1):55-63. PubMed ID: 9012687
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
19. Plant-produced human recombinant erythropoietic growth factors support erythroid differentiation in vitro.
Musiychuk K; Sivalenka R; Jaje J; Bi H; Flores R; Shaw B; Jones RM; Golovina T; Schnipper J; Khandker L; Sun R; Li C; Kang L; Voskinarian-Berse V; Zhang X; Streatfield S; Hambor J; Abbot S; Yusibov V
Stem Cells Dev; 2013 Aug; 22(16):2326-40. PubMed ID: 23517237
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
